Annual Accounts Payable
$15.57 M
+$3.22 M+26.05%
December 31, 2023
Summary
- As of February 7, 2025, ADCT annual accounts payable is $15.57 million, with the most recent change of +$3.22 million (+26.05%) on December 31, 2023.
- During the last 3 years, ADCT annual accounts payable has risen by +$10.29 million (+194.92%).
- ADCT annual accounts payable is now at all-time high.
Performance
ADCT Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$14.37 M
+$3.66 M+34.22%
September 30, 2024
Summary
- As of February 7, 2025, ADCT quarterly accounts payable is $14.37 million, with the most recent change of +$3.66 million (+34.22%) on September 30, 2024.
- Over the past year, ADCT quarterly accounts payable has dropped by -$1.20 million (-7.69%).
- ADCT quarterly accounts payable is now -12.65% below its all-time high of $16.45 million, reached on March 31, 2022.
Performance
ADCT Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
ADCT Accounts Payable Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +26.1% | -7.7% |
3 y3 years | +194.9% | +19.0% |
5 y5 years | +130.7% | +19.0% |
ADCT Accounts Payable Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +28.9% | -12.7% | +65.3% |
5 y | 5-year | at high | +367.7% | -12.7% | +331.7% |
alltime | all time | at high | +625.8% | -12.7% | +1132.6% |
ADC Therapeutics SA Accounts Payable History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $14.37 M(+34.2%) |
Jun 2024 | - | $10.71 M(-25.2%) |
Mar 2024 | - | $14.31 M(-8.1%) |
Dec 2023 | $15.57 M(+26.1%) | $15.57 M(+73.4%) |
Sep 2023 | - | $8.98 M(-23.2%) |
Jun 2023 | - | $11.69 M(+34.5%) |
Mar 2023 | - | $8.69 M(-29.6%) |
Dec 2022 | $12.35 M(+2.2%) | $12.35 M(+6.4%) |
Sep 2022 | - | $11.61 M(-10.8%) |
Jun 2022 | - | $13.02 M(-20.9%) |
Mar 2022 | - | $16.45 M(+36.2%) |
Dec 2021 | $12.08 M | $12.08 M(+0.4%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2021 | - | $12.03 M(-17.8%) |
Jun 2021 | - | $14.63 M(+27.6%) |
Mar 2021 | - | $11.46 M(+117.1%) |
Dec 2020 | $5.28 M(+58.6%) | $5.28 M(-14.1%) |
Sep 2020 | - | $6.15 M(-9.6%) |
Jun 2020 | - | $6.80 M(+104.2%) |
Dec 2019 | $3.33 M(-50.7%) | - |
Dec 2019 | - | $3.33 M(+185.5%) |
Jun 2019 | - | $1.17 M(-82.7%) |
Dec 2018 | $6.75 M(-11.4%) | - |
Dec 2018 | - | $6.75 M |
Dec 2017 | $7.62 M(+255.2%) | - |
Dec 2016 | $2.15 M | - |
FAQ
- What is ADC Therapeutics SA annual accounts payable?
- What is the all time high annual accounts payable for ADC Therapeutics SA?
- What is ADC Therapeutics SA annual accounts payable year-on-year change?
- What is ADC Therapeutics SA quarterly accounts payable?
- What is the all time high quarterly accounts payable for ADC Therapeutics SA?
- What is ADC Therapeutics SA quarterly accounts payable year-on-year change?
What is ADC Therapeutics SA annual accounts payable?
The current annual accounts payable of ADCT is $15.57 M
What is the all time high annual accounts payable for ADC Therapeutics SA?
ADC Therapeutics SA all-time high annual accounts payable is $15.57 M
What is ADC Therapeutics SA annual accounts payable year-on-year change?
Over the past year, ADCT annual accounts payable has changed by +$3.22 M (+26.05%)
What is ADC Therapeutics SA quarterly accounts payable?
The current quarterly accounts payable of ADCT is $14.37 M
What is the all time high quarterly accounts payable for ADC Therapeutics SA?
ADC Therapeutics SA all-time high quarterly accounts payable is $16.45 M
What is ADC Therapeutics SA quarterly accounts payable year-on-year change?
Over the past year, ADCT quarterly accounts payable has changed by -$1.20 M (-7.69%)